Position
Squarepoint Ops LLC in Zentalis Pharmaceuticals, Inc.
Back to the book · All holders of ZNTL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $30.4K$1.35 → $2.34
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 107.7K | $145.4K | — | — | — | 0.0% |
| Q1 2026 | 30.7K | $71.8K | $2.34 | $30.4K | −$104K | 0.0% |